Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves: Comparison of SAPIEN 3 Ultra Versus SAPIEN 3.

[1]  A. Colombo,et al.  Comparison of Transfemoral Versus Transradial Secondary Access in Transcatheter Aortic Valve Replacement , 2020, Circulation. Cardiovascular interventions.

[2]  G. Tarantini,et al.  In-hospital and thirty-day outcomes of the SAPIEN 3 Ultra balloon-expandable transcatheter aortic valve: the S3U registry , 2020 .

[3]  P. Leprince,et al.  Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement , 2019, Circulation.

[4]  B. Prendergast,et al.  Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial , 2019, The Lancet.

[5]  Adnan Kastrati,et al.  Evaluación multicéntrica del sobredimensionamiento de la prótesis transcatéter SAPIEN 3. Impacto en el fallo del dispositivo y nuevos implantes de marcapasos , 2019, Revista Española de Cardiología.

[6]  M. Kofler,et al.  Balloon-expandable transcatheter aortic valve implantation with or without pre-dilation – results of a meta-analysis of 3 multicenter registries , 2019, BMC Cardiovascular Disorders.

[7]  S. Achenbach,et al.  Transvascular transcatheter aortic valve implantation in 2017 , 2019, Clinical Research in Cardiology.

[8]  C. Hengstenberg,et al.  One year VARC-2-defined clinical outcomes after transcatheter aortic valve implantation with the SAPIEN 3 , 2019, Clinical Research in Cardiology.

[9]  J. Leipsic,et al.  Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[10]  Andrew S. Mugglin,et al.  Transcatheter Aortic‐Valve Replacement with a Self‐Expanding Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[11]  J. Leipsic,et al.  The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study. , 2019, JACC. Cardiovascular interventions.

[12]  V. Nkomo,et al.  Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections , 2018, European heart journal.

[13]  R. Lange,et al.  Conscious Sedation Versus General Anesthesia in Transcatheter Aortic Valve Replacement: The German Aortic Valve Registry. , 2018, JACC. Cardiovascular interventions.

[14]  C. Grines,et al.  Does mild paravalvular regurgitation post transcatheter aortic valve implantation affect survival? A meta‐analysis , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[15]  C. Hengstenberg,et al.  Parallel suture technique with ProGlide: a novel method for management of vascular access during transcatheter aortic valve implantation (TAVI). , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[16]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.

[17]  Michael Joner,et al.  Standardized Minimalistic Transfemoral Transcatheter Aortic Valve Replacement (TAVR) Using the SAPIEN 3 Device: Stepwise Description, Feasibility, and Safety from a Large Consecutive Single-Center Single-Operator Cohort , 2017 .

[18]  F. Neumann,et al.  SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve. , 2017, Circulation.

[19]  H. Takagi,et al.  Impact of paravalvular aortic regurgitation after transcatheter aortic valve implantation on survival. , 2016, International journal of cardiology.

[20]  H. Baumgartner,et al.  Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height. , 2016, JACC. Cardiovascular interventions.

[21]  M. Mack,et al.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.

[22]  C. Hengstenberg,et al.  Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience. , 2015, JACC. Cardiovascular interventions.

[23]  L. Räber,et al.  Procedural Results and Clinical Outcomes of Transcatheter Aortic Valve Implantation in Switzerland: An Observational Cohort Study of Sapien 3 Versus Sapien XT Transcatheter Heart Valves , 2015, Circulation. Cardiovascular interventions.

[24]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[25]  M. Mack,et al.  Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. , 2015, European heart journal.

[26]  J. Leipsic,et al.  Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. , 2014, Journal of the American College of Cardiology.

[27]  P. Leprince,et al.  Postprocedural Aortic Regurgitation in Balloon-Expandable and Self-Expandable Transcatheter Aortic Valve Replacement Procedures: Analysis of Predictors and Impact on Long-Term Mortality Insights From the FRANCE2 Registry , 2014, Circulation.

[28]  J. Leipsic,et al.  Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. , 2013, JACC. Cardiovascular interventions.

[29]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.

[30]  D. Dvir,et al.  The minimalist approach for transcatheter aortic valve replacement in high-risk patients. , 2012, JACC: Cardiovascular Interventions.

[31]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[32]  Stuart J Pocock,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.